Novalis provides cloud-connected lab automation and bioinformatic design tools for gene and cell therapy researchers, cutting synthesis-to-validation cycles from 6 weeks to 10 days. The Sydney biotech firm partners with UNSW's Translational Research Centre and has served 14 pharma and research organisations in Australia and NZ. Their open-source DNA design library is used by 200+ academic labs globally.